PURPOSE: Information is required about recovery after injury, including general health measures such as the EQ-5D. This project aimed to: (1) search for studies of injury outcome using the EQ-5D, (2) describe EQ-5D administration and analysis, (3) summarize reliability and validity, and (4) report EQ-5D outcomes. METHODS: A systematic search was undertaken for publications (January 1990 to May 2008). Studies were excluded if the EQ-5D was not used or if injury was a secondary outcome or resulted from a degenerative condition. RESULTS: Of 79 potentially eligible articles retrieved, 35 were excluded and 44 remained. Sample sizes ranged between n = 14 and n = 3,231. Two thirds of studies described injury outcomes, the remainder focused on specific treatments after injury. Of studies reporting EQ-5D index scores, most used the UK value set, and 29% did not specify a value set. In 16 studies, the EQ-5D was self-completed by participants, and in others, administration was by interviewer, proxy, or unspecified. Time of administration varied between 6 days and 7 years after injury. The absence of a cognitive dimension in the EQ-5D was a concern. DISCUSSION: Given the global impact of injury-related disability, our search supports calls for comprehensive population-level research exploring outcomes. Many studies considered only specific treatments after injury, had small sample sizes, or were undertaken in wealthy countries. Although noting reservations about the EQ-5D, such as the absence of a cognitive dimension; the EQ-SD being freely available to nonprofit-making organizations, and with many language versions available, seems suitable for studies in wealthy and poorer nations alike.
PURPOSE: Information is required about recovery after injury, including general health measures such as the EQ-5D. This project aimed to: (1) search for studies of injury outcome using the EQ-5D, (2) describe EQ-5D administration and analysis, (3) summarize reliability and validity, and (4) report EQ-5D outcomes. METHODS: A systematic search was undertaken for publications (January 1990 to May 2008). Studies were excluded if the EQ-5D was not used or if injury was a secondary outcome or resulted from a degenerative condition. RESULTS: Of 79 potentially eligible articles retrieved, 35 were excluded and 44 remained. Sample sizes ranged between n = 14 and n = 3,231. Two thirds of studies described injury outcomes, the remainder focused on specific treatments after injury. Of studies reporting EQ-5D index scores, most used the UK value set, and 29% did not specify a value set. In 16 studies, the EQ-5D was self-completed by participants, and in others, administration was by interviewer, proxy, or unspecified. Time of administration varied between 6 days and 7 years after injury. The absence of a cognitive dimension in the EQ-5D was a concern. DISCUSSION: Given the global impact of injury-related disability, our search supports calls for comprehensive population-level research exploring outcomes. Many studies considered only specific treatments after injury, had small sample sizes, or were undertaken in wealthy countries. Although noting reservations about the EQ-5D, such as the absence of a cognitive dimension; the EQ-SD being freely available to nonprofit-making organizations, and with many language versions available, seems suitable for studies in wealthy and poorer nations alike.
Authors: Suzanne J Wilson; Gabrielle Davie; Helen Harcombe; Emma H Wyeth; Ian D Cameron; Sarah Derrett Journal: Qual Life Res Date: 2018-08-21 Impact factor: 4.147
Authors: Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek Journal: Qual Life Res Date: 2016-07-29 Impact factor: 4.147
Authors: Suzanne Polinder; Juanita A Haagsma; Eefje Belt; Ronan A Lyons; Vicki Erasmus; Johan Lund; Ed F van Beeck Journal: BMC Public Health Date: 2010-12-23 Impact factor: 3.295
Authors: Belinda J Gabbe; Emma McDermott; Pam M Simpson; Sarah Derrett; Shanthi Ameratunga; Suzanne Polinder; Ronan A Lyons; Frederick P Rivara; James E Harrison Journal: Popul Health Metr Date: 2015-06-13
Authors: Belinda J Gabbe; Pam M Simpson; Ronan A Lyons; Shanthi Ameratunga; James E Harrison; Sarah Derrett; Suzanne Polinder; Gabrielle Davie; Frederick P Rivara Journal: PLoS One Date: 2014-12-11 Impact factor: 3.240
Authors: Melita J Giummarra; Katharine S Baker; Liane Ioannou; Stella M Gwini; Stephen J Gibson; Carolyn A Arnold; Jennie Ponsford; Peter Cameron Journal: BMJ Open Date: 2017-10-05 Impact factor: 2.692